Clarification

The article "Looking Back At Jenner, Vaccine Developers Prepare For 21st Century" (K.S. Brown, The Scientist, April 1, 1996, page 14) reported incorrect information concerning clinical trials of Malvern, Pa.-based Apollon Inc.'s HIV-directed, DNA-based vaccine. The Phase I/II clinical trial is being conducted at the National Institutes of Health Clinical Center in Bethesda, Md. University of Pennsylvania investigators, under the direction of David Weiner, collaborated in the development of the

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The article "Looking Back At Jenner, Vaccine Developers Prepare For 21st Century" (K.S. Brown, The Scientist, April 1, 1996, page 14) reported incorrect information concerning clinical trials of Malvern, Pa.-based Apollon Inc.'s HIV-directed, DNA-based vaccine. The Phase I/II clinical trial is being conducted at the National Institutes of Health Clinical Center in Bethesda, Md. University of Pennsylvania investigators, under the direction of David Weiner, collaborated in the development of the vaccine.

Following the commentary in the Aug. 19, 1996, issue of The Scientist (E. Garfield, "An Old Proposal For A New Profession: Scientific Reviewing," page 12), an incorrect URL was given for the bibliography of Essays of an Information Scientist, a 15-volume series in which all Current Contents commentaries from 1962 through 1993 have been reprinted. The correct URL is as follows: http://165.123.33.33/eugene_garfield/essays.html.

In the article "Reports Give Boost To Xenotransplantation As Researchers Wait For Federal Guidelines" (R. Finn, The ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies